Compare with GUJ.THEMIS. - Equitymaster

Helping You Build Wealth With Honest Research
Since 1996. Try Now

  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

SUVEN PHARMACEUTICALS vs GUJ.THEMIS. - Comparison Results

Rs 100 invested in...

Loading...
DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    SUVEN PHARMACEUTICALS GUJ.THEMIS. SUVEN PHARMACEUTICALS/
GUJ.THEMIS.
 
P/E (TTM) x 40.1 18.6 215.6% View Chart
P/BV x 11.0 10.6 103.2% View Chart
Dividend Yield % 0.4 0.0 -  

Financials

 SUVEN PHARMACEUTICALS   GUJ.THEMIS.
EQUITY SHARE DATA
    SUVEN PHARMACEUTICALS
Mar-21
GUJ.THEMIS.
Mar-21
SUVEN PHARMACEUTICALS/
GUJ.THEMIS.
5-Yr Chart
Click to enlarge
High Rs525304 172.9%   
Low Rs103102 100.8%   
Sales per share (Unadj.) Rs39.762.3 63.6%  
Earnings per share (Unadj.) Rs12.120.8 58.4%  
Cash flow per share (Unadj.) Rs13.422.0 60.9%  
Dividends per share (Unadj.) Rs2.000-  
Avg Dividend yield %0.60-  
Book value per share (Unadj.) Rs46.448.1 96.4%  
Shares outstanding (eoy) m254.5714.53 1,752.0%   
Bonus / Rights / Conversions ---  
Price / Sales ratio x7.93.3 243.2%   
Avg P/E ratio x25.99.8 265.2%  
P/CF ratio (eoy) x23.59.2 254.4%  
Price / Book Value ratio x6.84.2 160.6%  
Dividend payout %16.50-   
Avg Mkt Cap Rs m79,9532,948 2,711.9%   
No. of employees `000NANA-   
Total wages/salary Rs m76271 1,071.7%   
Avg. sales/employee Rs ThNMNM-  
Avg. wages/employee Rs ThNMNM-  
Avg. net profit/employee Rs ThNMNM-  
INCOME DATA
Net Sales Rs m10,097906 1,114.9%  
Other income Rs m14233 435.8%   
Total revenues Rs m10,240938 1,091.3%   
Gross profit Rs m4,430403 1,098.5%  
Depreciation Rs m31617 1,825.5%   
Interest Rs m11710 1,189.1%   
Profit before tax Rs m4,139409 1,012.5%   
Minority Interest Rs m00-   
Prior Period Items Rs m00-   
Extraordinary Inc (Exp) Rs m00-   
Tax Rs m1,053107 984.2%   
Profit after tax Rs m3,086302 1,022.6%  
Gross profit margin %43.944.5 98.5%  
Effective tax rate %25.426.2 97.2%   
Net profit margin %30.633.3 91.7%  
BALANCE SHEET DATA
Current assets Rs m6,665734 908.5%   
Current liabilities Rs m3,215259 1,242.9%   
Net working cap to sales %34.252.4 65.2%  
Current ratio x2.12.8 73.1%  
Inventory Days Days20016 1,263.5%  
Debtors Days Days370593 62.4%  
Net fixed assets Rs m9,097249 3,647.0%   
Share capital Rs m25573 350.5%   
"Free" reserves Rs m11,554627 1,843.2%   
Net worth Rs m11,808699 1,688.1%   
Long term debt Rs m3560-   
Total assets Rs m15,762983 1,603.3%  
Interest coverage x36.542.7 85.5%   
Debt to equity ratio x00-  
Sales to assets ratio x0.60.9 69.5%   
Return on assets %20.331.7 64.1%  
Return on equity %26.143.1 60.6%  
Return on capital %35.059.9 58.5%  
Exports to sales %00-   
Imports to sales %00-   
Exports (fob) Rs mNANA-   
Imports (cif) Rs mNANA-   
Fx inflow Rs m9,9020-   
Fx outflow Rs m1,3695 25,779.7%   
Net fx Rs m8,533-5 -160,704.3%   
CASH FLOW
From Operations Rs m3,834105 3,641.0%  
From Investments Rs m-3,114-23 13,827.6%  
From Financial Activity Rs m-766-52 1,482.4%  
Net Cashflow Rs m-4531 -144.9%  

Share Holding

Indian Promoters % 60.0 75.0 80.0%  
Foreign collaborators % 0.0 0.0 -  
Indian inst/Mut Fund % 13.8 0.0 46,133.3%  
FIIs % 8.0 0.0 -  
ADR/GDR % 0.0 0.0 -  
Free float % 40.0 25.0 159.9%  
Shareholders   96,532 12,930 746.6%  
Pledged promoter(s) holding % 0.0 0.0 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare SUVEN PHARMACEUTICALS With:   EMMESSAR CHM  COLINZ LABOR  ADESHWAR MEDITEX  INDOCO REMEDIES  CIPLA  



Today's Market

Sensex Snaps 2-Day Losing Streak, Zooms 887 Points, Nifty Settles Above 17,150; Tata Steel, Axis Bank Top Gainers(Closing)

Indian share markets witnessed positive trading activity throughout the day today and ended on a strong note.

Related Views on News

SUVEN PHARMACEUTICALS 2020-21 Annual Report Analysis (Annual Result Update)

Sep 6, 2021 | Updated on Sep 6, 2021

Here's an analysis of the annual report of SUVEN PHARMACEUTICALS for 2020-21. It includes a full income statement, balance sheet and cash flow analysis of SUVEN PHARMACEUTICALS. Also includes updates on the valuation of SUVEN PHARMACEUTICALS.

5 Stocks to Watch Out for Amid the Omicron Outbreak (Views On News)

Dec 3, 2021

As the new variant of Covid-19 emerges, keep an eye on these stocks.

This Stock Just Made a Historical Debut on the Exchanges (Views On News)

Nov 15, 2021

Shares of the company listed at premium of 253% from its IPO price, the highest ever.

3 Indian Pharma Companies that are Investing Big Time for the Future (Views On News)

Nov 9, 2021

In 2021, R&D of pharma companies roared to life in a never-before-seen way.

Demerger of Financial & Pharma Businesses puts Piramal Enterprises in Limelight (Views On News)

Oct 8, 2021

The company's shareholders will be issued 4 shares in the demerged entity for every 1 held in Piramal Enterprises.

More Views on News

Most Popular

Infosys vs TCS: Which is Better?(Views On News)

Nov 26, 2021

In the post pandemic era, the top two IT companies in India are fighting to capture the growing demand for IT.

This Multibagger Stock Zooms 20% After Dolly Khanna Buys Stake(Views On News)

Nov 24, 2021

Shares of this edible oil company zoomed over 50% in three days after ace investor bought around 1% stake.

6 Popular Stocks that Turned into Penny Stocks(Views On News)

Nov 27, 2021

A look at popular stocks that crashed big time and never recovered, i.e. which went from 'Multibaggers to Multibeggers'.

India's Top 5 Monopoly Stocks to Watch Out for(Views On News)

Nov 30, 2021

These 5 companies dominate their sectors with a huge piece of the pie.

The Biggest Winners and Losers in India's Transition to Electric Vehicles(Profit Hunter)

Nov 26, 2021

How India's EV transition could be a major headwind for the incumbents.

More

Become A Smarter Investor
In Just 5 Minutes

Multibagger Stock Guide 2022
Get our special report Multibagger Stocks Guide (2022 Edition) Now!
We will never sell or rent your email id.
Please read our Terms

SUVEN PHARMACEUTICALS SHARE PRICE


Dec 7, 2021 (Close)

TRACK SUVEN PHARMACEUTICALS

  • Track your investment in SUVEN PHARMACEUTICALS with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

MORE ON SUVEN PHARMACEUTICALS

SUVEN PHARMACEUTICALS - SOURCE NATURAL FOODS COMPARISON

COMPARE SUVEN PHARMACEUTICALS WITH

MARKET STATS